276 related articles for article (PubMed ID: 22643842)
1. Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil- DNA glycosylase.
Do H; Dobrovic A
Oncotarget; 2012 May; 3(5):546-58. PubMed ID: 22643842
[TBL] [Abstract][Full Text] [Related]
2. Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies.
Do H; Dobrovic A
Mol Cancer; 2009 Oct; 8():82. PubMed ID: 19811662
[TBL] [Abstract][Full Text] [Related]
3. Reducing sequence artifacts in amplicon-based massively parallel sequencing of formalin-fixed paraffin-embedded DNA by enzymatic depletion of uracil-containing templates.
Do H; Wong SQ; Li J; Dobrovic A
Clin Chem; 2013 Sep; 59(9):1376-83. PubMed ID: 23649127
[TBL] [Abstract][Full Text] [Related]
4. Awareness of mutational artefacts in suboptimal DNA samples: possible risk for therapeutic choices.
Mariani S; Bertero L; Coppola V; Saracco G; Arezzo A; Francia Di Celle P; Metovic J; Marchiò C; Cassoni P
Expert Rev Mol Diagn; 2018 May; 18(5):467-475. PubMed ID: 29676606
[TBL] [Abstract][Full Text] [Related]
5. High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies.
Do H; Krypuy M; Mitchell PL; Fox SB; Dobrovic A
BMC Cancer; 2008 May; 8():142. PubMed ID: 18495026
[TBL] [Abstract][Full Text] [Related]
6. Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
Sie D; Snijders PJ; Meijer GA; Doeleman MW; van Moorsel MI; van Essen HF; Eijk PP; Grünberg K; van Grieken NC; Thunnissen E; Verheul HM; Smit EF; Ylstra B; Heideman DA
Cell Oncol (Dordr); 2014 Oct; 37(5):353-61. PubMed ID: 25209392
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of uracil DNA glycosylase pretreatment in amplicon-based massively parallel sequencing with DNA extracted from archived formalin-fixed paraffin-embedded esophageal cancer tissues.
Serizawa M; Yokota T; Hosokawa A; Kusafuka K; Sugiyama T; Tsubosa Y; Yasui H; Nakajima T; Koh Y
Cancer Genet; 2015 Sep; 208(9):415-27. PubMed ID: 26194062
[TBL] [Abstract][Full Text] [Related]
8. KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
Heideman DA; Lurkin I; Doeleman M; Smit EF; Verheul HM; Meijer GA; Snijders PJ; Thunnissen E; Zwarthoff EC
J Mol Diagn; 2012; 14(3):247-55. PubMed ID: 22425762
[TBL] [Abstract][Full Text] [Related]
9. Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.
Wong SQ; Li J; Tan AY; Vedururu R; Pang JM; Do H; Ellul J; Doig K; Bell A; MacArthur GA; Fox SB; Thomas DM; Fellowes A; Parisot JP; Dobrovic A;
BMC Med Genomics; 2014 May; 7():23. PubMed ID: 24885028
[TBL] [Abstract][Full Text] [Related]
10. Mutation detection of epidermal growth factor receptor and KRAS genes using the smart amplification process version 2 from formalin-fixed, paraffin-embedded lung cancer tissue.
Miyamae Y; Shimizu K; Mitani Y; Araki T; Kawai Y; Baba M; Kakegawa S; Sugano M; Kaira K; Lezhava A; Hayashizaki Y; Yamamoto K; Takeyoshi I
J Mol Diagn; 2010 Mar; 12(2):257-64. PubMed ID: 20093389
[TBL] [Abstract][Full Text] [Related]
11. High-resolution melting analysis as a sensitive prescreening diagnostic tool to detect KRAS , BRAF , PIK3CA , and AKT1 mutations in formalin-fixed, paraffin-embedded tissues.
Ney JT; Froehner S; Roesler A; Buettner R; Merkelbach-Bruse S
Arch Pathol Lab Med; 2012 Sep; 136(9):983-92. PubMed ID: 22938585
[TBL] [Abstract][Full Text] [Related]
12. Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.
Tuononen K; Mäki-Nevala S; Sarhadi VK; Wirtanen A; Rönty M; Salmenkivi K; Andrews JM; Telaranta-Keerie AI; Hannula S; Lagström S; Ellonen P; Knuuttila A; Knuutila S
Genes Chromosomes Cancer; 2013 May; 52(5):503-11. PubMed ID: 23362162
[TBL] [Abstract][Full Text] [Related]
13. Reducing Artifactual
Do H; Molania R; Mitchell PL; Vaiskunaite R; Murdoch JD; Dobrovic A
Clin Chem; 2017 Sep; 63(9):1506-1514. PubMed ID: 28720682
[TBL] [Abstract][Full Text] [Related]
14. Variation in pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection: a diagnostic RING trial.
Kapp JR; Diss T; Spicer J; Gandy M; Schrijver I; Jennings LJ; Li MM; Tsongalis GJ; de Castro DG; Bridge JA; Wallace A; Deignan JL; Hing S; Butler R; Verghese E; Latham GJ; Hamoudi RA
J Clin Pathol; 2015 Feb; 68(2):111-8. PubMed ID: 25430497
[TBL] [Abstract][Full Text] [Related]
15. Impact of fixation artifacts and threshold selection on high resolution melting analysis for KRAS mutation screening.
Pérez-Báez W; García-Latorre EA; Maldonado-Martínez HA; Coronado-Martínez I; Flores-García L; Taja-Chayeb L
Mol Cell Probes; 2017 Oct; 35():34-43. PubMed ID: 28627450
[TBL] [Abstract][Full Text] [Related]
16. Duplex reverse-hybridization assay for the simultaneous detection of KRAS/BRAF mutations in FFPE-extracted genomic DNA from colorectal cancer specimens.
Buxhofer-Ausch V; Ausch C; Zeillinger R; Oberkanins C; Dandachi N; Reiner-Concin A; Kriegshäuser G
Dis Markers; 2013; 34(3):171-7. PubMed ID: 23324583
[TBL] [Abstract][Full Text] [Related]
17. Assessment of a fully automated high-throughput DNA extraction method from formalin-fixed, paraffin-embedded tissue for KRAS, and BRAF somatic mutation analysis.
van Eijk R; Stevens L; Morreau H; van Wezel T
Exp Mol Pathol; 2013 Feb; 94(1):121-5. PubMed ID: 22750048
[TBL] [Abstract][Full Text] [Related]
18. Deamination Effects in Formalin-Fixed, Paraffin-Embedded Tissue Samples in the Era of Precision Medicine.
Kim S; Park C; Ji Y; Kim DG; Bae H; van Vrancken M; Kim DH; Kim KM
J Mol Diagn; 2017 Jan; 19(1):137-146. PubMed ID: 27840062
[TBL] [Abstract][Full Text] [Related]
19. Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue.
Hedegaard J; Thorsen K; Lund MK; Hein AM; Hamilton-Dutoit SJ; Vang S; Nordentoft I; Birkenkamp-Demtröder K; Kruhøffer M; Hager H; Knudsen B; Andersen CL; Sørensen KD; Pedersen JS; Ørntoft TF; Dyrskjøt L
PLoS One; 2014; 9(5):e98187. PubMed ID: 24878701
[TBL] [Abstract][Full Text] [Related]
20. Applicability of a System for fully automated nucleic acid extraction from formalin-fixed paraffin-embedded sections for routine KRAS mutation testing.
Lehmann A; Schewe C; Hennig G; Denkert C; Weichert W; Budczies J; Dietel M
Diagn Mol Pathol; 2012 Jun; 21(2):114-9. PubMed ID: 22555094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
